137 related articles for article (PubMed ID: 11668203)
1. Usefulness of supernatant of pancreatic juice for genetic analysis of K-ras in diagnosis of pancreatic carcinoma.
Ha A; Watanabe H; Yamaguchi Y; Ohtsubo K; Wang Y; Motoo Y; Okai T; Wakabayahi T; Sawabu N
Pancreas; 2001 Nov; 23(4):356-63. PubMed ID: 11668203
[TBL] [Abstract][Full Text] [Related]
2. Quantitative determination of K-ras mutations in pancreatic juice for diagnosis of pancreatic cancer using hybridization protection assay.
Watanabe H; Yamaguchi Y; Ha A; Hu YX; Motoo Y; Okai T; Yoshimura T; Sawabu N
Pancreas; 1998 Nov; 17(4):341-7. PubMed ID: 9821175
[TBL] [Abstract][Full Text] [Related]
3. K-ras mutations in duodenal aspirate without secretin stimulation for screening of pancreatic and biliary tract carcinoma.
Watanabe H; Ha A; Hu YX; Ohtsubo K; Yamaguchi Y; Motoo Y; Okai T; Toya D; Tanaka N; Sawabu N
Cancer; 1999 Oct; 86(8):1441-8. PubMed ID: 10526271
[TBL] [Abstract][Full Text] [Related]
4. Detection of p53 gene mutations in the supernatant of pancreatic juice and plasma from patients with pancreatic carcinomas.
Wang Y; Yamaguchi Y; Watanabe H; Ohtsubo K; Motoo Y; Sawabu N
Pancreas; 2004 Jan; 28(1):13-9. PubMed ID: 14707724
[TBL] [Abstract][Full Text] [Related]
5. Preproenkephalin hypermethylation in the pure pancreatic juice compared with p53 mutation in the diagnosis of pancreatic carcinoma.
Ohtsubo K; Watanabe H; Yao F; Okada G; Mouri H; Yamaguchi Y; Sawabu N
J Gastroenterol; 2006 Aug; 41(8):791-7. PubMed ID: 16988769
[TBL] [Abstract][Full Text] [Related]
6. Serum tumor markers and molecular biological diagnosis in pancreatic cancer.
Sawabu N; Watanabe H; Yamaguchi Y; Ohtsubo K; Motoo Y
Pancreas; 2004 Apr; 28(3):263-7. PubMed ID: 15084968
[TBL] [Abstract][Full Text] [Related]
7. Aberrant methylation of secreted apoptosis-related protein 2 (SARP2) in pure pancreatic juice in diagnosis of pancreatic neoplasms.
Watanabe H; Okada G; Ohtsubo K; Yao F; Jiang PH; Mouri H; Wakabayashi T; Sawabu N
Pancreas; 2006 May; 32(4):382-9. PubMed ID: 16670620
[TBL] [Abstract][Full Text] [Related]
8. Identification of K-ras oncogene mutations in the pure pancreatic juice of patients with ductal pancreatic cancers.
Watanabe H; Sawabu N; Ohta H; Satomura Y; Yamakawa O; Motoo Y; Okai T; Takahashi H; Wakabayashi T
Jpn J Cancer Res; 1993 Sep; 84(9):961-5. PubMed ID: 8407563
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic utility of aberrant methylation of tissue factor pathway inhibitor 2 in pure pancreatic juice for pancreatic carcinoma.
Jiang P; Watanabe H; Okada G; Ohtsubo K; Mouri H; Tsuchiyama T; Yao F; Sawabu N
Cancer Sci; 2006 Nov; 97(11):1267-73. PubMed ID: 16965396
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of cytology and tumor markers of pure pancreatic juice for the diagnosis of pancreatic cancer at early stages.
Matsumoto S; Harada H; Tanaka J; Ochi K; Seno T; Tsurumi T; Kunichika K
Pancreas; 1994 Nov; 9(6):741-7. PubMed ID: 7846018
[TBL] [Abstract][Full Text] [Related]
11. Detection of K-ras point mutations at codon 12 in pure pancreatic juice for the diagnosis of pancreatic cancer by PCR-RFLP analysis.
Watanabe H; Sawabu N; Songür Y; Yamaguchi Y; Yamakawa O; Satomura Y; Ohta H; Motoo Y; Okai T; Wakabayashi T
Pancreas; 1996 Jan; 12(1):18-24. PubMed ID: 8927616
[TBL] [Abstract][Full Text] [Related]
12. Analysis of K-ras codon 12 point mutations using duodenal lavage fluid for diagnosis of pancreatic carcinoma.
Nakamura Y; Onda M; Uchida E
Pancreas; 1999 Mar; 18(2):133-40. PubMed ID: 10090410
[TBL] [Abstract][Full Text] [Related]
13. Detection of K-ras point mutations at codon 12 in pancreatic juice for the diagnosis of pancreatic cancer by hybridization protection assay: a simple method for the determination of the types of point mutation.
Watanabe H; Miyagi C; Yamaguchi Y; Satomura Y; Ohta H; Motoo Y; Okai T; Yoshimura T; Tsuji Y; Sawabu N
Jpn J Cancer Res; 1996 May; 87(5):466-74. PubMed ID: 8641983
[TBL] [Abstract][Full Text] [Related]
14. Expression of mesothelin mRNA in pure pancreatic juice from patients with pancreatic carcinoma, intraductal papillary mucinous neoplasm of the pancreas, and chronic pancreatitis.
Watanabe H; Okada G; Ohtsubo K; Yamaguchi Y; Mouri H; Motoo Y; Wakabayashi T; Sawabu N
Pancreas; 2005 May; 30(4):349-54. PubMed ID: 15841046
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of pancreatic cancer by cytology and measurement of oncogene and tumor markers in pure pancreatic juice aspirated by endoscopy.
Nakaizumi A; Uehara H; Takenaka A; Uedo N; Sakai N; Yano H; Ohigashi H; Ishikawa O; Ishiguro S; Sugano K; Tatsuta M
Hepatogastroenterology; 1999; 46(25):31-7. PubMed ID: 10228761
[TBL] [Abstract][Full Text] [Related]
16. Detection of Ki-ras and p53 gene mutations in tissue and pancreatic juice from pancreatic adenocarcinomas.
Kondoh S; Kaino M; Okita S; Ryozawa S; Akiyama T; Okita K
J Gastroenterol; 1998 Jun; 33(3):390-6. PubMed ID: 9658319
[TBL] [Abstract][Full Text] [Related]
17. [K-ras mutation in pancreatic juice from patients with pancreatic carcinoma].
Gong X; Chen Y; Chen Y; Lu X
Zhonghua Nei Ke Za Zhi; 1999 Oct; 38(10):673-6. PubMed ID: 11798705
[TBL] [Abstract][Full Text] [Related]
18. [Clinical usefulness of tumor markers associated with pancreatic cancer].
Watanabe H; Kawakami H; Yamakawa O; Satomura Y; Ohta H; Motoo Y; Okai T; Sawabu N
Rinsho Byori; 1994 Feb; 42(2):127-38. PubMed ID: 7908065
[TBL] [Abstract][Full Text] [Related]
19. Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma.
Kondo H; Sugano K; Fukayama N; Kyogoku A; Nose H; Shimada K; Ohkura H; Ohtsu A; Yoshida S; Shimosato Y
Cancer; 1994 Mar; 73(6):1589-94. PubMed ID: 8156485
[TBL] [Abstract][Full Text] [Related]
20. Detection of K-ras point mutation at codon 12 in pure pancreatic juice collected 3 years and 6 months before the clinical diagnosis of pancreatic cancer.
Wakabayashi T; Sawabu N; Watanabe H; Morimoto H; Sugioka G; Takita Y
Am J Gastroenterol; 1996 Sep; 91(9):1848-51. PubMed ID: 8792713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
